- Home
- KRNY vs KMDA Comparison
KRNY vs KMDA Comparison
Compare KRNY & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRNY
- KMDA
- Stock Information
- Founded
- KRNY 1884
- KMDA 1990
- Country
- KRNY United States
- KMDA Israel
- Employees
- KRNY N/A
- KMDA N/A
- Industry
- KRNY Savings Institutions
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- KRNY Finance
- KMDA Health Care
- Exchange
- KRNY Nasdaq
- KMDA Nasdaq
- Market Cap
- KRNY 420.7M
- KMDA 410.6M
- IPO Year
- KRNY 2005
- KMDA N/A
- Fundamental
- Price
- KRNY $6.61
- KMDA $7.14
- Analyst Decision
- KRNY Buy
- KMDA Strong Buy
- Analyst Count
- KRNY 2
- KMDA 2
- Target Price
- KRNY $7.75
- KMDA $13.00
- AVG Volume (30 Days)
- KRNY 408.9K
- KMDA 51.8K
- Earning Date
- KRNY 10-23-2025
- KMDA 08-13-2025
- Dividend Yield
- KRNY 6.66%
- KMDA 2.80%
- EPS Growth
- KRNY N/A
- KMDA 27.97
- EPS
- KRNY 0.42
- KMDA 0.32
- Revenue
- KRNY $151,629,000.00
- KMDA $169,517,000.00
- Revenue This Year
- KRNY $14.22
- KMDA $14.49
- Revenue Next Year
- KRNY N/A
- KMDA $10.12
- P/E Ratio
- KRNY $15.85
- KMDA $21.69
- Revenue Growth
- KRNY 12.84
- KMDA 9.67
- 52 Week Low
- KRNY $5.45
- KMDA $5.17
- 52 Week High
- KRNY $8.59
- KMDA $9.16
- Technical
- Relative Strength Index (RSI)
- KRNY 60.69
- KMDA 48.75
- Support Level
- KRNY $6.54
- KMDA $6.90
- Resistance Level
- KRNY $6.88
- KMDA $7.11
- Average True Range (ATR)
- KRNY 0.16
- KMDA 0.19
- MACD
- KRNY 0.05
- KMDA 0.01
- Stochastic Oscillator
- KRNY 70.00
- KMDA 45.28
About KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.